| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.94B | 3.00B | 12.62B | 13.18B | 8.51B | 19.08B |
| Gross Profit | 13.94B | 3.00B | 12.62B | 13.18B | 8.51B | 19.08B |
| EBITDA | 0.00 | 2.85B | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 1.33B | 1.19B | 1.58B | 1.17B | 1.63B | 3.28B |
Balance Sheet | ||||||
| Total Assets | 206.11B | 204.91B | 210.38B | 208.94B | 217.11B | 251.59B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 6.40B | 112.98B | 118.31B | 88.56B | 114.81B |
| Total Debt | 13.08B | 13.69B | 11.53B | 14.10B | 15.40B | 12.24B |
| Total Liabilities | 184.38B | 183.76B | 188.72B | 187.82B | 199.28B | 216.67B |
| Stockholders Equity | 21.64B | 19.08B | 21.57B | 19.62B | 17.77B | 34.65B |
Cash Flow | ||||||
| Free Cash Flow | 249.00M | -2.35B | -401.00M | 62.00M | -8.22B | -2.64B |
| Operating Cash Flow | 249.00M | -2.35B | -401.00M | 62.00M | -8.18B | -2.59B |
| Investing Cash Flow | 1.10B | 1.10B | 2.56B | 4.53B | 6.08B | -1.83B |
| Financing Cash Flow | -393.00M | 794.00M | -3.41B | -2.99B | 1.76B | -741.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €15.63B | 5.57 | 11.85% | 2.07% | 2.01% | 79.48% | |
60 Neutral | €69.69B | 12.40 | 12.05% | 5.10% | 0.12% | -2.71% | |
58 Neutral | €10.10B | 10.61 | 14.36% | 5.79% | -6.64% | ― | |
57 Neutral | €23.92B | 14.95 | 9.85% | 4.36% | -12.70% | -12.34% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | €12.76B | 6.94 | 6.31% | 5.32% | 16.35% | 67.44% | |
53 Neutral | €17.98B | ― | 6.47% | 5.40% | -15.54% | 10.53% |